Scheduled Medicines Expert Committee

Consistent with the AHMAC Guidance, Ahpra has established a Scheduled Medicines Expert Committee (the Expert Committee) whose role is to advise National Boards on:

  • the use of scheduled medicines generally, and
  • matters relevant to a National Board’s proposal for a new scheduled medicines endorsement or an amendment to an existing scheduled medicines endorsement.

Information about committee members is available on the Committee members page.

Terms of reference

Page reviewed 12/04/2021